The Superbug Crisis: Why Hospitals Must Act Now
When the world gained control over COVID-19, infection control experts did not get a break. Instead, hospitals must now confront a secondary emergency: the pandemic lying in wait—antibiotic resistance.
For decades, dangerous pathogens have outsmarted the antibiotics that revolutionized modern medicine. Well before COVID-19 emerged, drug-resistant "superbugs" were a growing global threat. They caused 700,000 deaths annually while straining critical hospital resources.
Bacterial resistance had risen above 70%—including resistance to every antibiotic ever developed for intensive care units. Treatments for routine infections required increasingly toxic regimens. This crisis only intensified when SARS-CoV-2 spread worldwide.
“In the shadows of the COVID-19 pandemic,” Croatian researchers warned, “there has been an ongoing antimicrobial resistance pandemic.”
An Accelerating Global Threat
The superbug crisis is primed to accelerate rapidly. Millions of patients took unneeded antibiotics during the pandemic. Meanwhile, patients with drug-resistant tuberculosis experienced severe treatment interruptions. At the same time, critical research into new antibiotics halted.
Together, these factors risk triggering lethal new variants and dangerous hospital outbreaks. Without immediate intervention, routine medical procedures—such as C-sections, knee replacements, and chemotherapy—will carry far higher risks.
“We might soon head toward a post-antibiotic era, where a simple wound or dental infection can be fatal,” warns Hatim Sati, M.D., a member of the WHO task force on antimicrobial resistance. “That is what is at stake here.”
The Critical Role of Continuous Air Disinfection
Hospitals must respond on two fronts: dispensing antibiotics more judiciously and expanding infection control precautions. Continuous air disinfection is essential to this strategy.
Hand hygiene and surface cleaning remain important. However, hand rub alone cannot stop airborne pathogens from circulating through medical facilities.
The U.S. Centers for Disease Control and Prevention (CDC) classifies several airborne pathogens as urgent or serious threats. These include Mycobacterium tuberculosis, Methicillin-resistant Staphylococcus aureus (MRSA), Carbapenem-resistant Acinetobacter, and Clostridium difficile.
“Uncontrolled air movement inside hospitals makes bacterial persistence worse,” a study team noted in the Annals of Clinical Microbiology and Antimicrobials, “since infectious microorganisms spread easily through coughing, talking, and medical contact.”
Routine tasks—mopping floors, changing bedding, cutting bandages, or removing gloves—can propel superbugs into the air. These infectious aerosols hover for hours and travel widely across facility ducts.
Hospitals must equip their facilities to neutralize airborne superbugs continuously before they reach vulnerable patients or open surgical sites.
How COVID-19 Amplified Antibiotic Resistance
Antibiotics cannot treat viral infections like COVID-19, influenza, or the common cold. Yet clinicians frequently prescribe them anyway—a practice that accelerates resistance.
Before 2020, over 30% of oral antibiotic prescriptions were unnecessary. During the height of the pandemic, that figure surged.
Early on, clinicians struggled to distinguish COVID-19 from bacterial pneumonia, prescribing antibiotics by default. Others prescribed them out of fear of secondary bacterial co-infections. In most instances, patients received antimicrobials before diagnostic tests confirmed an infection.
This trend spanned the globe:
- United States: Among COVID-19 patients across 38 hospitals, 56% received early antibiotic therapy, though only 3.5% had confirmed bacterial infections.
- Europe: Over 75% of severe COVID-19 patients received antimicrobials, while only 15% had documented bacterial cases.
- Asia: Medical centers reported similar overprescribing rates.
Additionally, the expansion of telemedicine increased antibiotic usage among non-COVID patients. Lacking physical exams or immediate lab tests, providers often prescribed antibiotics empirically.
“Antimicrobial stewardship may be another casualty of the COVID-19 pandemic,” researchers observed. Supply chain disruptions have also created shortages of frontline antibiotics and diagnostic testing kits worldwide.